Erika L. Flannery

Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics

Annie N. Cowell, Eva S. Istvan, Amanda K. Lukens et al. · Science · 2018 · 269 citations · Full text

High-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission

David Plouffe, Melanie Wree, Alan Y. Du et al. · Cell Host & Microbe · 2015 · 161 citations · Full text

KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission

Kelli Kuhen, Arnab K. Chatterjee, Matthias Rottmann et al. · Antimicrobial Agents and Chemotherapy · 2014 · 154 citations · Full text

Antiparasitic Agent, Malaria, Immunology +16

Mutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone Antimalarials

Erika L. Flannery, Case W. McNamara, Sang Wan Kim et al. · ACS Chemical Biology · 2014 · 98 citations · Full text

Antiparasitic Agent, Malaria, Molecular Biology +20

Proteogenomic analysis of the total and surface-exposed proteomes of Plasmodium vivax salivary gland sporozoites

Kristian E. Swearingen, Scott E. Lindner, Erika L. Flannery et al. · PLoS neglected tropical diseases · 2017 · 88 citations · Full text

Salivary Gland Sporozoites, Antiparasitic Agent, Malaria +16